The company reported a consolidated net profit of ₹243.3 crore for the quarter ended June 30, 2026, compared with ₹117.2 crore in the corresponding period last year, marking a significant improvement in earnings.
Revenue from operations increased 44.1% year-on-year to ₹1,045.1 crore from ₹725.4 crore a year earlier, driven by growth across key business segments.
Operating performance improved at a faster pace than revenue growth. Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 72.7% to ₹357 crore from ₹206 crore in the year-ago quarter.
As a result, EBITDA margin expanded to 34.2% from 28.5% in the corresponding period last year. EBITDA margin reflects the operating profit generated from each rupee of revenue, and the expansion indicates that the company was able to improve profitability while scaling up sales.
The quarterly performance highlights the benefits of stronger volumes, improved realisations and better operating leverage across Navin Fluorine’s businesses.
Board approves ₹90 crore investment for advanced materials
The company’s board has approved a capital expenditure of ₹90 crore to establish adoption capacities at its Surat facility.
Navin Fluorine said the investment will help advance products under its Advanced Materials portfolio from the laboratory stage to commercial-scale qualification.
The move is aimed at strengthening the company’s capabilities in specialised fluorochemical applications, where customers typically require extensive testing and qualification before large-scale commercial production begins.
High Performance Products business sees momentum
Navin Fluorine said its High Performance Products (HPP) business continued to benefit from volume growth and higher realisations during the quarter.
The company added that the pricing environment for hydrofluorocarbons (HFCs) remained constructive, supporting business performance.
The company’s acid hydrofluoric (AHF) facility, which was commissioned in the fourth quarter of FY26, is currently being ramped up. AHF is a key raw material used in fluorochemical manufacturing.
The company also said additional HFC capacity equivalent to up to 15,000 metric tonnes per annum (MTPA) of R32 remains on track for commissioning in the third quarter of FY27. R32 is a refrigerant used in air-conditioning applications.
Specialty chemicals, CDMO businesses remain key focus areas
In its Specialty Chemicals segment, Navin Fluorine said growth continues to be supported by strong order visibility and a healthy product pipeline.
The company said the Chemours project is targeted for completion by the end of the second quarter of FY27, while the de-bottlenecking of its multi-purpose plant (MPP) capacity at Dahej remains on track for commissioning in the third quarter of FY27.
The company’s contract development and manufacturing organisation (CDMO) business also continued to show momentum, supported by its order book and deeper engagement with a European CDMO major.
CDMO companies work with pharmaceutical and chemical companies to develop and manufacture specialised products, providing long-term revenue opportunities through customer partnerships.
Navin Fluorine said Phase II of its cGMP4 expansion project, involving an investment of ₹125 crore, is expected to become operational by the fourth quarter of FY27. This follows the operationalisation of Phase I in the third quarter of FY26.
The company said it remains focused on building a balanced portfolio across commercial and early-stage molecules while expanding its presence across therapeutic areas such as oncology, respiratory, cardiovascular, neurology and animal health.
Focus remains on specialty fluorochemicals growth
Navin Fluorine’s latest performance reflects the company’s strategy of moving beyond commodity fluorochemicals towards higher-value specialty products and contract manufacturing opportunities.
The company continues to invest in capacity expansion, customer partnerships and product development capabilities as demand grows for advanced materials and specialised chemical applications.
Shares of Navin Fluorine International Ltd ended 0.12% lower at ₹7,620 on Wednesday, ahead of the company’s June-quarter earnings announcement.
Also Read: Novelis Q1 profit jumps 71% as Hindalco arm gains from aluminium demand, cost savings
